FDA Issues Early Alert for Becton Dickinson Convenience Kits
Certain procedure trays contain recalled sodium chloride ampules that may pose a risk of infection or organ failure.
Certain procedure trays contain recalled sodium chloride ampules that may pose a risk of infection or organ failure.
Use with select infusion sets may lead to over- or under-infusion, bolus inaccuracies, and alarm delays, BD warns in recall notice.
BD launched a new, advanced ultrasound device with a specialized probe designed to provide clinicians with optimal IV placement.
Certain procedure trays contain recalled sodium chloride ampules that may pose a risk of infection or organ failure.
Serious cybersecurity vulnerabilities on certain BD products are being addressed and will be included in an upcoming software update.
Read MoreMedical device companies saw a strong return for most of their business units this year following major sales losses that occurred in 2020.
Read MoreIn a recent panel hosted by medical device manufacturer BD, three healthcare security professionals came together to discuss cybersecurity issues, including strategies to help protect medical devices from cyberattacks.
Read MoreIn this article, BD’s Rob Suárez shares three strategies that can help healthcare providers and medical device manufacturers work together to manage medical device cybersecurity amid increasing cyber-risks.
Read MoreThrough the BD 2020 Cybersecurity Report, the company seeks to address cybersecurity challenges specific to healthcare and offer guidance about cybersecurity practices for working with medical device manufacturers.
Read MoreBD has issued a statement to make users aware of a BD Alaris 8015 PC Unit and BD Alaris Systems Manager Network Session Vulnerability.
Read MoreBD subsidiary CME America announces a voluntary recall for all CME America BodyGuard Infusion System Administration Sets—used with the company’s BodyGuard infusion pumps—that were distributed beginning May 2016.